Charles River Laboratories International, Inc. (CRL)
USD 99.06
(-0.9%)
USD 99.06
(-0.9%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.5 Billion USD | 2.73% |
| 2022 | 1.46 Billion USD | 9.59% |
| 2021 | 1.33 Billion USD | 24.32% |
| 2020 | 1.07 Billion USD | 12.02% |
| 2019 | 958.31 Million USD | 14.08% |
| 2018 | 840.06 Million USD | 19.61% |
| 2017 | 702.31 Million USD | 8.61% |
| 2016 | 646.66 Million USD | 21.76% |
| 2015 | 531.09 Million USD | 12.36% |
| 2014 | 472.66 Million USD | 19.69% |
| 2013 | 394.9 Million USD | 0.72% |
| 2012 | 392.08 Million USD | -2.53% |
| 2011 | 402.24 Million USD | 4.54% |
| 2010 | 384.76 Million USD | -10.39% |
| 2009 | 429.36 Million USD | -15.93% |
| 2008 | 510.7 Million USD | 6.8% |
| 2007 | 478.19 Million USD | 17.61% |
| 2006 | 406.6 Million USD | -5.16% |
| 2005 | 428.73 Million USD | 43.6% |
| 2004 | 298.56 Million USD | 27.78% |
| 2003 | 233.66 Million USD | 11.81% |
| 2002 | 208.98 Million USD | 24.95% |
| 2001 | 167.25 Million USD | 23.77% |
| 2000 | 135.13 Million USD | 37.37% |
| 1999 | 98.37 Million USD | 39.03% |
| 1998 | 70.75 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 335.46 Million USD | 4.77% |
| 2024 Q1 | 320.19 Million USD | -12.06% |
| 2023 Q4 | 364.08 Million USD | 0.62% |
| 2023 Q3 | 361.84 Million USD | -9.31% |
| 2023 Q2 | 398.97 Million USD | 5.65% |
| 2023 FY | 1.5 Billion USD | 2.73% |
| 2023 Q1 | 377.65 Million USD | -5.32% |
| 2022 Q1 | 336.81 Million USD | -2.97% |
| 2022 Q3 | 370.22 Million USD | 16.22% |
| 2022 Q4 | 398.88 Million USD | 7.74% |
| 2022 FY | 1.46 Billion USD | 9.59% |
| 2022 Q2 | 318.55 Million USD | -5.42% |
| 2021 Q3 | 337.22 Million USD | -1.4% |
| 2021 Q1 | 308.27 Million USD | 2.77% |
| 2021 Q4 | 347.11 Million USD | 2.93% |
| 2021 FY | 1.33 Billion USD | 24.32% |
| 2021 Q2 | 342.02 Million USD | 10.95% |
| 2020 Q2 | 232.23 Million USD | -7.86% |
| 2020 FY | 1.07 Billion USD | 12.02% |
| 2020 Q4 | 299.96 Million USD | 3.7% |
| 2020 Q3 | 289.27 Million USD | 24.56% |
| 2020 Q1 | 252.06 Million USD | -3.91% |
| 2019 Q4 | 262.31 Million USD | 6.58% |
| 2019 Q1 | 211.77 Million USD | -6.47% |
| 2019 Q2 | 238.1 Million USD | 12.43% |
| 2019 Q3 | 246.11 Million USD | 3.36% |
| 2019 FY | 958.31 Million USD | 14.08% |
| 2018 FY | 840.06 Million USD | 19.61% |
| 2018 Q3 | 216.2 Million USD | 0.1% |
| 2018 Q4 | 226.41 Million USD | 4.73% |
| 2018 Q2 | 215.98 Million USD | 19.02% |
| 2018 Q1 | 181.46 Million USD | 8.18% |
| 2017 Q3 | 177.2 Million USD | -4.56% |
| 2017 Q2 | 185.66 Million USD | 8.13% |
| 2017 Q1 | 171.69 Million USD | -4.55% |
| 2017 Q4 | 167.74 Million USD | -5.34% |
| 2017 FY | 702.31 Million USD | 8.61% |
| 2016 Q4 | 179.88 Million USD | 15.11% |
| 2016 Q1 | 140.76 Million USD | 0.14% |
| 2016 Q3 | 156.27 Million USD | -7.94% |
| 2016 Q2 | 169.74 Million USD | 20.59% |
| 2016 FY | 646.66 Million USD | 21.76% |
| 2015 FY | 531.09 Million USD | 12.36% |
| 2015 Q1 | 119.66 Million USD | -0.24% |
| 2015 Q2 | 132.78 Million USD | 10.97% |
| 2015 Q3 | 138.07 Million USD | 3.99% |
| 2015 Q4 | 140.57 Million USD | 1.81% |
| 2014 Q2 | 125.63 Million USD | 15.46% |
| 2014 Q4 | 119.94 Million USD | 1.42% |
| 2014 FY | 472.66 Million USD | 19.69% |
| 2014 Q1 | 108.81 Million USD | 23.38% |
| 2014 Q3 | 118.26 Million USD | -5.86% |
| 2013 FY | 394.9 Million USD | 0.72% |
| 2013 Q4 | 88.19 Million USD | -11.74% |
| 2013 Q3 | 99.92 Million USD | -2.58% |
| 2013 Q2 | 102.57 Million USD | -1.57% |
| 2013 Q1 | 104.21 Million USD | 14.49% |
| 2012 Q2 | 103.58 Million USD | -0.6% |
| 2012 FY | 392.08 Million USD | -2.53% |
| 2012 Q3 | 93.25 Million USD | -9.97% |
| 2012 Q1 | 104.21 Million USD | 3.62% |
| 2012 Q4 | 91.02 Million USD | -2.4% |
| 2011 Q1 | 102.63 Million USD | 9.63% |
| 2011 Q2 | 106.32 Million USD | 3.59% |
| 2011 Q3 | 92.71 Million USD | -12.8% |
| 2011 Q4 | 100.56 Million USD | 8.47% |
| 2011 FY | 402.24 Million USD | 4.54% |
| 2010 Q2 | 100.36 Million USD | 0.45% |
| 2010 FY | 384.76 Million USD | -10.39% |
| 2010 Q1 | 99.91 Million USD | -0.2% |
| 2010 Q3 | 90.85 Million USD | -9.47% |
| 2010 Q4 | 93.62 Million USD | 3.05% |
| 2009 FY | 429.36 Million USD | -15.93% |
| 2009 Q1 | 108.22 Million USD | -3.44% |
| 2009 Q2 | 114.46 Million USD | 5.77% |
| 2009 Q3 | 106.56 Million USD | -6.9% |
| 2009 Q4 | 100.12 Million USD | -6.05% |
| 2008 Q4 | 112.07 Million USD | -13.97% |
| 2008 FY | 510.7 Million USD | 6.8% |
| 2008 Q3 | 130.27 Million USD | -5.59% |
| 2008 Q2 | 137.98 Million USD | 5.84% |
| 2008 Q1 | 130.37 Million USD | 10.71% |
| 2007 Q2 | 120.95 Million USD | 4.66% |
| 2007 FY | 478.19 Million USD | 17.61% |
| 2007 Q1 | 115.57 Million USD | 13.61% |
| 2007 Q3 | 123.89 Million USD | 2.43% |
| 2007 Q4 | 117.76 Million USD | -4.95% |
| 2006 Q4 | 101.73 Million USD | -0.52% |
| 2006 Q1 | 103.18 Million USD | -2.24% |
| 2006 Q2 | 107.11 Million USD | 3.8% |
| 2006 FY | 406.6 Million USD | -5.16% |
| 2006 Q3 | 102.26 Million USD | -4.53% |
| 2005 Q1 | 104.61 Million USD | 22.04% |
| 2005 Q2 | 111.78 Million USD | 6.86% |
| 2005 Q3 | 106.79 Million USD | -4.47% |
| 2005 Q4 | 105.54 Million USD | -1.17% |
| 2005 FY | 428.73 Million USD | 43.6% |
| 2004 FY | 298.56 Million USD | 27.78% |
| 2004 Q1 | 68.82 Million USD | 15.47% |
| 2004 Q2 | 74.62 Million USD | 8.42% |
| 2004 Q3 | 69.39 Million USD | -7.0% |
| 2004 Q4 | 85.72 Million USD | 23.52% |
| 2003 FY | 233.66 Million USD | 11.81% |
| 2003 Q3 | 56.49 Million USD | -5.19% |
| 2003 Q4 | 59.6 Million USD | 5.51% |
| 2003 Q1 | 57.98 Million USD | 9.09% |
| 2003 Q2 | 59.58 Million USD | 2.76% |
| 2002 Q4 | 53.14 Million USD | -0.61% |
| 2002 Q3 | 53.47 Million USD | 2.05% |
| 2002 Q2 | 52.4 Million USD | 4.89% |
| 2002 Q1 | 49.95 Million USD | 14.56% |
| 2002 FY | 208.98 Million USD | 24.95% |
| 2001 Q1 | 36.66 Million USD | 6.52% |
| 2001 FY | 167.25 Million USD | 23.77% |
| 2001 Q4 | 43.6 Million USD | 0.92% |
| 2001 Q3 | 43.21 Million USD | -1.28% |
| 2001 Q2 | 43.77 Million USD | 19.39% |
| 2000 FY | 135.13 Million USD | 37.37% |
| 2000 Q4 | 34.41 Million USD | 2.28% |
| 2000 Q3 | 33.65 Million USD | 3.84% |
| 2000 Q1 | 34.65 Million USD | 0.0% |
| 2000 Q2 | 32.41 Million USD | -6.47% |
| 1999 FY | 98.37 Million USD | 39.03% |
| 1998 FY | 70.75 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Agilent Technologies, Inc. | 3.46 Billion USD | 56.636% |
| Quest Diagnostics Incorporated | 2.96 Billion USD | 49.255% |
| Danaher Corporation | 14.03 Billion USD | 89.293% |
| Enzo Biochem, Inc. | 14.63 Million USD | -10168.972% |
| IQVIA Holdings Inc. | 5.23 Billion USD | 71.32% |
| Laboratory Corporation of America Holdings | 3.36 Billion USD | 55.346% |
| Mettler-Toledo International Inc. | 2.24 Billion USD | 32.96% |
| Qiagen N.V. | 1.22 Billion USD | -22.866% |
| Revvity, Inc. | 1.17 Billion USD | -27.923% |
| Thermo Fisher Scientific Inc. | 15.22 Billion USD | 90.13% |
| Waters Corporation | 1.76 Billion USD | 14.685% |